Marshall Wace’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.8M Buy
297,635
+282,706
+1,894% +$29M 0.03% 564
2025
Q4
$1.58M Sell
14,929
-71,291
-83% -$8.26M ﹤0.01% 1687
2025
Q3
$11M Sell
86,220
-196,902
-70% -$23.4M 0.01% 887
2025
Q2
$34.7M Buy
+283,122
New +$32.3M 0.04% 399
2023
Q3
Sell
-10,549
Closed -$714K 2307
2023
Q2
$714K Sell
10,549
-196,004
-95% -$12.3M ﹤0.01% 1854
2023
Q1
$11.2M Buy
+206,553
New +$12M 0.02% 674
2022
Q4
Sell
-4,800
Closed -$216K 3049
2022
Q3
$216K Sell
4,800
-55,526
-92% -$2.78M ﹤0.01% 3063
2022
Q2
$2.69M Sell
60,326
-34,811
-37% -$1.79M 0.01% 1791
2022
Q1
$5.38M Buy
+95,137
New +$4.97M 0.01% 1306
2020
Q1
Sell
-141,322
Closed -$7.79M 1728
2019
Q4
$7.79M Sell
141,322
-292,442
-67% -$15.9M 0.05% 372
2019
Q3
$21.8M Sell
433,764
-138,326
-24% -$6.95M 0.17% 137
2019
Q2
$28.8M Buy
572,090
+430,939
+305% +$20.9M 0.24% 87
2019
Q1
$6.56M Buy
141,151
+89,765
+175% +$4.55M 0.06% 387
2018
Q4
$2.52M Buy
+51,386
New +$2.92M 0.03% 668
2016
Q1
Sell
-148,546
Closed -$4.11M 1062
2015
Q4
$4.11M Buy
148,546
+104,511
+237% +$2.97M 0.04% 417
2015
Q3
$1.34M Sell
44,035
-4,185
-9% -$146K 0.02% 567
2015
Q2
$1.77M Buy
+48,220
New +$1.72M 0.02% 499

Other funds holding EHC

Marshall Wace's EHC Position: Q1 2026 in Review

Marshall Wace increased its Encompass Health (EHC) stake by 1,894% in Q1 2026, buying an estimated $29M and bringing the position to 297,635 shares worth $28.8M. The position accounts for 0.03% of the portfolio, ranked #564.

Marshall Wace first reported a position in EHC in Q2 2015 and has held it in 17 quarters since. The position peaked at $34.7M in Q2 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Marshall Wace held 297,635 shares of Encompass Health worth $28.8M as of Q1 2026.
  • Marshall Wace bought 282,706 Encompass Health shares in Q1 2026, an estimated $29M.
  • Encompass Health made up 0.03% of Marshall Wace's portfolio in Q1 2026, its #564 holding.
  • Marshall Wace first reported a position in Encompass Health in Q2 2015 and has held it in 17 quarters since.
  • Marshall Wace's Encompass Health position peaked at $34.7M in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.